Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EnsoData
AddedFeb 15, 2024
UpdatedJun 18, 2026
EnsoData

EnsoData

EnsoData: Advanced healthcare software provider, specializing in autoscoring solutions for sleep medicine.

HQ
Madison, WI, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

EnsoData was founded with the mission to revolutionize healthcare through advanced software solutions, focusing primarily on sleep medicine. Their flagship product, EnsoSleep, leverages sophisticated algorithms and adheres to American Academy of Sleep Medicine (AASM) scoring recommendations to provide highly accurate autoscoring for sleep studies. By analyzing every millisecond of physiological data, EnsoData aims to maximize diagnostic accuracy and efficiency, serving healthcare providers primarily in Wisconsin.

Notable figures associated with EnsoData include Laura Linley, CRT, RPSGT, FAAST, who serves as Co-Founder and VP of Clinical Operations. The company has achieved significant milestones, such as dramatically reducing the time required for sleep study report preparation and improving scoring consistency. These advancements have had a profound impact on the efficiency and accuracy of sleep diagnostics, positioning EnsoData as a key player in the healthcare software industry.

EnsoData - Similar Companies

Enso logo

Enso

ensoanalytics.com

Sleep.ai logo

Sleep.ai

sleep.ai

ESO Solutions logo

ESO Solutions

eso.com

Ilerasoft logo

Ilerasoft

Eon Health logo

Eon Health

ArborMetrix logo

ArborMetrix

arbormetrix.com

Etiometry logo

Etiometry

etiometry.com

Quantivly logo

Quantivly

quantivly.com

Ensemble AI logo

Ensemble AI

DataAppraisal logo

DataAppraisal

dataappraisal.ai

Appian Medical logo

Appian Medical

appianmed.com

ChartSynergy logo

ChartSynergy

Clarify Health Solutions logo

Clarify Health Solutions

clarifyhealth.com

Da'at Technologies logo

Da'at Technologies

sovaSage logo

sovaSage

sovasage.com

EnsoData - Quick Facts

Who are EnsoData's competitors?

Companies similar to EnsoData include Enso, Sleep.ai, ESO Solutions and Ilerasoft.

When was EnsoData founded?

EnsoData was founded in 2015.

Where is EnsoData's headquarters located?

EnsoData's headquarters is located in Madison, WI, US.

When was EnsoData's last funding round?

EnsoData's most recent funding round was for $20M (USD) in April 2022.

How much has EnsoData raised to-date?

As of Apr 27, 2022, EnsoData has raised a total of $31.1M (USD).

How many employees does EnsoData have?

EnsoData has 62 employees as of Feb 5, 2024.

EnsoData - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software